Woodline Partners’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Buy |
1,096,863
+54
| +0% | +$708 | 0.08% | 356 |
|
|
2025
Q1 | $24.1M | Buy |
1,096,809
+529,591
| +93% | +$11.7M | 0.16% | 190 |
|
|
2024
Q4 | $15.1M | Buy |
567,218
+39,379
| +7% | +$1.05M | 0.1% | 264 |
|
|
2024
Q3 | $14.1M | Buy |
527,839
+106,235
| +25% | +$2.84M | 0.12% | 238 |
|
|
2024
Q2 | $7.59M | Buy |
421,604
+16,472
| +4% | +$297K | 0.07% | 284 |
|
|
2024
Q1 | $7.39M | Buy |
405,132
+920
| +0.2% | +$16.8K | 0.07% | 311 |
|
|
2023
Q4 | $4.42M | Buy |
404,212
+44,119
| +12% | +$483K | 0.05% | 328 |
|
|
2023
Q3 | $2.06M | Hold |
360,093
| – | – | 0.02% | 397 |
|
|
2023
Q2 | $2.79M | Hold |
360,093
| – | – | 0.03% | 383 |
|
|
2023
Q1 | $2.4M | Buy |
360,093
+2
| +0% | +$13 | 0.03% | 397 |
|
|
2022
Q4 | $3.22M | Sell |
360,091
-179,773
| -33% | -$1.61M | 0.04% | 385 |
|
|
2022
Q3 | $5.31M | Sell |
539,864
-231,933
| -30% | -$2.28M | 0.07% | 278 |
|
|
2022
Q2 | $6.14M | Buy |
771,797
+411,704
| +114% | +$3.28M | 0.09% | 229 |
|
|
2022
Q1 | $3.49M | Sell |
360,093
-42,756
| -11% | -$415K | 0.06% | 288 |
|
|
2021
Q4 | $6.16M | Buy |
402,849
+41,028
| +11% | +$627K | 0.09% | 258 |
|
|
2021
Q3 | $6.01M | Buy |
361,821
+7,332
| +2% | +$122K | 0.1% | 226 |
|
|
2021
Q2 | $7.56M | Sell |
354,489
-2,940
| -0.8% | -$62.7K | 0.14% | 174 |
|
|
2021
Q1 | $11.6M | Buy |
+357,429
| New | +$11.6M | 0.26% | 100 |
|